Sciencast Management’s Charles River Laboratories CRL Stock Holding History

Sciencast Management’s Portfolio CRL Stock Details CRL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	$1.31M	Buy	+5,297	New	+$1.29M	0.29%	120
2021 Q4	–	Sell	-3,430	Closed	-$1.4M	–	492
2021 Q3	$1.4M	Buy	+3,430	New	+$1.42M	0.4%	90
2021 Q1	–	Sell	-1,220	Closed	-$312K	–	519
2020 Q4	$312K	Buy	+1,220	New	+$291K	0.07%	348
2020 Q3	–	Sell	-2,400	Closed	-$447K	–	420
2020 Q2	$447K	Buy	+2,400	New	+$383K	0.11%	280

Other funds holding CRL

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Kayne Anderson Rudnick Investment Management Los Angeles, California $32.2B AUM 10.98% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return

Mackenzie Financial Toronto Ontario, Ontario, Canada $100B AUM 36.93% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Sciencast Management's CRL Position: Q2 2022 in Review

Sciencast Management opened a new position in Charles River Laboratories (CRL) in Q2 2022: 5,297 shares worth $1.31M. The stake represents 0.29% of the portfolio and ranks #120 among its holdings. This is a return to the name: Sciencast Management previously reported a position in CRL as recently as Q3 2021.

Sciencast Management first reported a position in CRL in Q2 2020 and has held it in 4 quarters since. The position peaked at $1.4M in Q3 2021. 627 funds tracked by Wall St. Rank hold CRL as of Q2 2022.

Sciencast Management held 5,297 shares of Charles River Laboratories worth $1.31M as of Q2 2022.
Charles River Laboratories was a new Sciencast Management position in Q2 2022.
Charles River Laboratories made up 0.29% of Sciencast Management's portfolio in Q2 2022, its #120 holding.
Sciencast Management first reported a position in Charles River Laboratories in Q2 2020 and has held it in 4 quarters since.
Sciencast Management's Charles River Laboratories position peaked at $1.4M in Q3 2021.
627 funds tracked by Wall St. Rank held Charles River Laboratories as of Q2 2022.

Based on Sciencast Management's 13F filing for Q2 2022, filed 3 Aug 2022.